NRC Health (NRC) closed at $24.26 on November 2, 2026, up 1.8% from the previous close, on volume of 99,982 shares (30-day average 100,725).
Data as of November 2, 2026.
No headlines found.
NRC Health Announces Third Quarter 2026 Results
Business Wire (Tue, 27-Oct 4:00 PM ET)
NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams
Business Wire (Mon, 26-Oct 3:00 PM ET)
Business Wire (Thu, 15-Oct 4:53 PM ET)
Business Wire (Mon, 21-Sep 10:45 AM ET)
KLAS First Look: NRC Health Rounding Earns 91.6 Overall Performance Score
Business Wire (Wed, 2-Sep 3:00 PM ET)
Mercy Earns National Honor for Excellence in Patient Experience
PRNewswire (Tue, 1-Sep 9:00 AM ET)
NRC Health Announces 2026 Award Winners Recognizing Excellence Across Healthcare
Business Wire (Tue, 1-Sep 9:00 AM ET)
NRC Health operates as a humanized healthcare and support organization. Its platform includes Listen, Understand, and Improve. The group provides solutions for Patient, Consumer, Employee, and Market experiences. The group's commitment to Human Understanding helps healthcare systems get to know the patients, families, consumers, employees, and communities it on a human level.
NRC Health trades on the NASDAQ stock market under the symbol NRC.
As of November 2, 2026, NRC stock price climbed to $24.26 with 99,982 million shares trading.
NRC has a beta of -0.08, meaning it tends to be less sensitive to market movements. NRC has a correlation of 0.00 to the broad based SPY ETF.
NRC has a market cap of $514.83 million. This is considered a Small Cap stock.
Last quarter NRC Health reported $38 million in Revenue and $.21 earnings per share. This beat revenue expectation by $3 million and met earnings estimates .
In the last 3 years, NRC traded as high as $43.98 and as low as $9.76.
The top ETF exchange traded funds that NRC belongs to (by Net Assets): VTI, IWM, DFAS, DES, VXF.
NRC has outperformed the market in the last year with a price return of +90.1% while the SPY ETF gained +11.7%. NRC has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +29.1% and +20.4%, respectively, while the SPY returned +1.7% and -1.5%, respectively.
NRC support price is $23.05 and resistance is $24.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that NRC shares will trade within this expected range on the day.